Status:
UNKNOWN
Comparison of Endoscopic and Laparoscopic Resection for Small Gastric Gastrointestinal Stromal Tumor
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Collaborating Sponsors:
Shenzhen Hospital of Southern Medical University
Conditions:
Therapeutic Value of Endoscopic and Laparoscopic Resection for Small Gastric Gastrointestinal Stromal Tumor
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Comparison of Endoscopic and Laparoscopic Resection for Small Gastric Gastrointestinal Stromal Tumor
Eligibility Criteria
Inclusion
- 18-70 years old Chinese;
- Definite diagnosis or endoscopic ultrasonography, CT and other highly suspected Chinese patients with gastric stromal tumors;
- Patients voluntarily signed informed consent and have been orally informed of the specific trial plan.
Exclusion
- Patients with gastric stromal tumors with distant metastasis who cannot be treated by laparoscopic surgery;
- Combined heart , cerebrovascular , liver , kidney , and hematopoietic system serious primary disease;
- gastric stromal tumors with severe digestive tract hemorrhage endanger the immediate surgical treatment of life;
- The investigator considers that it is not suitable for this test.
Key Trial Info
Start Date :
September 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT03471273
Start Date
September 18 2017
End Date
December 31 2021
Last Update
March 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanfang Hospistal
Guangzhou, Guangdong, China, 510515